Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -734.8% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 37.4 | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | -80.6% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 | 0.32 | (5.90) | (30.50)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-22 | 0.62 | (5.57) | (26.50)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-23 | 0.08 | (4.26) | (17.50)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-24 | 1.91 | (3.34) | (9.60)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Sep-25 | 0.56 | (4.33) | (5.66)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Interim Results | 30-Jun-2026 | 10:10 | RNS |
| Share Capital Reorganisation, PDMR & TVR | 29-May-2026 | 16:41 | RNS |
| Updated Timetable for Share Capital Reorganisation | 19-May-2026 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 2.10p |
| Change Today | -0.100p |
| % Change | -4.55 % |
| 52 Week High | 3.50 |
| 52 Week Low | 0.33 |
| Volume | 0 |
| Shares Issued | 522.93m |
| Market Cap | £10.98m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
You are here: research